Randomized Trial of Pulsed Corticosteroid Therapy for Primary Treatment of Kawasaki Disease

Abstract

Our data do not provide support for the addition of a single pulsed dose of intravenous methylprednisolone to conventional intravenous immune globulin therapy for the routine primary treatment of children with Kawasaki disease. (ClinicalTrials.gov number, NCT00132080 [ClinicalTrials.gov].)